세계의 혈액 및 혈장 성분 시장 :제품, 용도, 최종 사용자별 예측(2025-2030년)

The Blood & Plasma Components Market was valued at USD 43.84 billion in 2023, expected to reach USD 45.86 billion in 2024, and is projected to grow at a CAGR of 5.57%, to USD 64.11 billion by 2030.

The blood and plasma components market involves the separation, collection, and use of blood and its derivatives for medical and therapeutic applications. This sector includes whole blood, red blood cells, plasma, platelets, and other biological materials used in transfusions, medical treatments, and diagnostics. The necessity of these components lies in addressing medical emergencies, surgeries, chronic conditions like hemophilia, and immune deficiencies. They are centrally applied in hospitals, diagnostic centers, and research institutions. End-use scope spans healthcare providers, ambulatory services, and increasingly biotech firms analyzing novel therapies.

Key growth factors include an aging global population increasing demand for transfusion and therapy, advancements in research into the use of plasma derivatives, and the growing incidence of chronic diseases. Technological advancements in blood testing and collection methods also enhance the market. Potential opportunities lie in expanding plasma-derived treatments, capitalizing on innovations in use-cases like convalescent plasma therapy for viral infections, and entering emerging economies where the infrastructure for blood component services is under development. To maximize these opportunities, strategic partnerships with healthcare providers and regulatory bodies for streamlined operations may be beneficial.

Limitations affecting growth include stringent regulatory frameworks that may impede rapid scaling of component production, the challenges in maintaining donor supply chains, and the risk of disease transmission which necessitates rigorous screening processes. Market challenges also stem from competition from synthetic and alternative therapies. Innovations and research focus should be directed towards improving the efficiency and safety of collection methods, developing portable collection devices, and leveraging AI for better inventory and demand forecasting. The market is inherently resilient, owing to its critical role in healthcare, but it requires ongoing adaptation to technological and regulatory changes to sustain growth. Understanding and intervening in these areas could facilitate improved service delivery and business expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood & Plasma Components Market

The Blood & Plasma Components Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of surgical procedures and need for safe blood & plasma components
  • Government initiatives encouraging blood & plasma donation campaigns
  • Improvements in blood-related disorders and transfusion medicine
• Market Restraints
  • Limitations associated with storage and shelf life of blood & plasma products
• Market Opportunities
  • Advancements in blood collection, processing, and storage technologies
  • Emerging adoption of immunoglobulin replacement therapy and clotting factor concentrates
• Market Challenges
  • Strict regulations to ensure the safety & quality of blood & plasma products

Porter's Five Forces: A Strategic Tool for Navigating the Blood & Plasma Components Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood & Plasma Components Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood & Plasma Components Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood & Plasma Components Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood & Plasma Components Market

A detailed market share analysis in the Blood & Plasma Components Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood & Plasma Components Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood & Plasma Components Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood & Plasma Components Market

A strategic analysis of the Blood & Plasma Components Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood & Plasma Components Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Laval Corporate AB, ANZCO Foods Limited, Beckman Coulter, Inc., Becton, Dickinson & Co., Bio-Rad Laboratories, Inc., BioChemed Services, bioMerieux SA, Biowest Company, CSL Behring LLC., Grifols, S.A., Immucor, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., MacoPharma, Meiji Holdings Co., Ltd., Moregate Biotech, Octapharma AG, Pel-Freez, LLC, Rockland Immunochemicals, Inc. by BroadOak Capital Partners, Sanquin, and TCS Biosciences Ltd..

Market Segmentation & Coverage

This research report categorizes the Blood & Plasma Components Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Plasma-Derived and Transfusion.
• Based on Application, market is studied across Hematology and Solid Tumor Management.
• Based on End User, market is studied across Diagnostics Laboratories, Hospitals, Research Institutions, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of surgical procedures and need for safe blood & plasma components
    • 5.1.1.2. Government initiatives encouraging blood & plasma donation campaigns
    • 5.1.1.3. Improvements in blood-related disorders and transfusion medicine
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations associated with storage and shelf life of blood & plasma products
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in blood collection, processing, and storage technologies
    • 5.1.3.2. Emerging adoption of immunoglobulin replacement therapy and clotting factor concentrates
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations to ensure the safety & quality of blood & plasma products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood & Plasma Components Market, by Product

• 6.1. Introduction
• 6.2. Plasma-Derived
• 6.3. Transfusion

7. Blood & Plasma Components Market, by Application

• 7.1. Introduction
• 7.2. Hematology
• 7.3. Solid Tumor Management

8. Blood & Plasma Components Market, by End User

• 8.1. Introduction
• 8.2. Diagnostics Laboratories
• 8.3. Hospitals
• 8.4. Research Institutions
• 8.5. Specialty Clinics

9. Americas Blood & Plasma Components Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood & Plasma Components Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood & Plasma Components Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alfa Laval Corporate AB
• 3. ANZCO Foods Limited
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson & Co.
• 6. Bio-Rad Laboratories, Inc.
• 7. BioChemed Services
• 8. bioMerieux SA
• 9. Biowest Company
• 10. CSL Behring LLC.
• 11. Grifols, S.A.
• 12. Immucor
• 13. Lake Immunogenics, Inc.
• 14. LAMPIRE Biological Laboratories, Inc.
• 15. MacoPharma
• 16. Meiji Holdings Co., Ltd.
• 17. Moregate Biotech
• 18. Octapharma AG
• 19. Pel-Freez, LLC
• 20. Rockland Immunochemicals, Inc. by BroadOak Capital Partners
• 21. Sanquin
• 22. TCS Biosciences Ltd.